Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75,885 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Associations between comorbidities and annual incidence plus frequency of asthma exacerbation hospitalisation during the past year: data from CARN study.
Wang W, Lin J, Zhou X, Wang C, Huang M, Cai S, Chen P, Lin Q, Zhou J, Gu Y, Yuan Y, Sun D, Yang X, Yang L, Huo J, Chen Z, Jiang P, Zhang J, Ye X, Liu H, Tang H, Liu R, Liu C, Zhang W, Hu C, Chen Y, Liu X, Dai L, Zhou W, Huang Y, Xu J. Wang W, et al. Among authors: huang m, huang y. BMC Pulm Med. 2022 Jul 1;22(1):261. doi: 10.1186/s12890-022-02038-3. BMC Pulm Med. 2022. PMID: 35778740 Free PMC article.
Asthma Management Using the Mobile Asthma Evaluation and Management System in China.
Lin J, Wang W, Tang H, Huo J, Gu Y, Liu R, Chen P, Yuan Y, Yang X, Xu J, Sun D, Li N, Jiang S, Chen Y, Wang C, Yang L, Liu X, Yang D, Zhang W, Chen Z, Lin Q, Liu C, Zhou J, Zhou X, Hu C, Jiang P, Zhou W, Zhang J, Cai S, Qiu C, Huang M, Huang Y, Liu H; China Asthma Research Collaboration Network. Lin J, et al. Among authors: huang m, huang y. Allergy Asthma Immunol Res. 2022 Jan;14(1):85-98. doi: 10.4168/aair.2022.14.1.85. Allergy Asthma Immunol Res. 2022. PMID: 34983109 Free PMC article.
Effectiveness of omalizumab in patients with severe allergic asthma: A retrospective study in China.
Zhang M, Jin M, Zhou X, Lin J, Liu X, Liu C, Huang M, Wang W, Chen L, Huang Y, Li J, Zhang Q, Shen H, Yu Y, Tang W, Zhou J, Liu H, Dong L, Hu Y, Wu H, Li Y, Song W, Ouyang M, Yuan X, Wang T, Xiong S. Zhang M, et al. Among authors: huang m, huang y. Respir Med. 2021 Sep;186:106522. doi: 10.1016/j.rmed.2021.106522. Epub 2021 Jun 29. Respir Med. 2021. PMID: 34229289 Free article.
Efficacy predictors of omalizumab in Chinese patients with moderate-to-severe allergic asthma: Findings from a post-hoc analysis of a randomised phase III study.
Li J, Wang C, Liu C, Kang J, Kong L, Huang Y, Liu S, Huang M, Wang L, Fogel R, Jaumont X, Yang J, Zhong N. Li J, et al. Among authors: huang m, huang y. World Allergy Organ J. 2020 Nov 24;13(12):100469. doi: 10.1016/j.waojou.2020.100469. eCollection 2020 Dec. World Allergy Organ J. 2020. PMID: 34611470 Free PMC article.
Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians.
Li J, Yang J, Kong L, Huang Y, Chen P, Yan X, Liu X, Zho X, Liu J, Zhu X, Humphries M, Wang L, Pethe A, Wang X, Kottakis I, Fogel R, Zhong N. Li J, et al. Among authors: huang y. Asian Pac J Allergy Immunol. 2022 Sep;40(3):223-231. doi: 10.12932/AP-260819-0630. Asian Pac J Allergy Immunol. 2022. PMID: 32247304 Free article.
A randomized, controlled, multicenter clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus moxifloxacin in adult patients with community-acquired pneumonia.
Li Y, Zhu D, Peng Y, Tong Z, Ma Z, Xu J, Sun S, Tang H, Xiu Q, Liang Y, Wang X, Lv X, Dai Y, Zhu Y, Qu Y, Xu K, Huang Y, Wu S, Lai G, Li X, Han X, Yang Z, Sheng J, Liu Z, Li H, Chen Y, Zhu H, Zhang Y. Li Y, et al. Among authors: huang y. Curr Med Res Opin. 2021 Apr;37(4):693-701. doi: 10.1080/03007995.2021.1885362. Epub 2021 Feb 22. Curr Med Res Opin. 2021. PMID: 33534617 Clinical Trial.
Expert consensus for diagnosis and treatment using medical thoracoscopy in China.
Jin F, Wang H, Li Q, Li S, Lai G, Huang J, Huang Y, Jiang T, Bai C, Li S, Li W, Lu Y, Song Y, Sun R, Chen C, Zhang J, Zhang X, Zhou R, Zhou X, Chen Y, Du Y, Hu C, Zhou H. Jin F, et al. Among authors: huang j, huang y. J Thorac Dis. 2020 May;12(5):1799-1810. doi: 10.21037/jtd-19-2276. J Thorac Dis. 2020. PMID: 32642085 Free PMC article. Review.
Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study.
Wang C, Sun T, Huang Y, Humphries M, Bai L, Li L, Wang Q, Kho P, Firth R, D'Andrea P. Wang C, et al. Among authors: huang y. Int J Chron Obstruct Pulmon Dis. 2015 Jan 5;10:57-68. doi: 10.2147/COPD.S72650. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 25609940 Free PMC article. Clinical Trial.
A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer - The FALUCA study.
Lu S, Chen G, Sun Y, Sun S, Chang J, Yao Y, Chen Z, Ye F, Lu J, Shi J, He J, Liu X, Zhang Y, Liu Z, Fang J, Cheng Y, Hu C, Mao W, Hu Y, Gong Y, Shan L, Yang Z, Song Y, Li W, Bai C, Wang B, Ma R, Zheng Z, Liu M, Jie Z, Cao L, Liao W, Pan H, Huang D, Chen Y, Yang J, Qin S, Ma S, Liang L, Liu Z, Zhou J, Tao M, Huang Y, Qiu F, Huang Y, Guan S, Peng M, Su W. Lu S, et al. Among authors: huang d, huang y. Lung Cancer. 2020 Aug;146:252-262. doi: 10.1016/j.lungcan.2020.06.016. Epub 2020 Jun 20. Lung Cancer. 2020. PMID: 32592986 Clinical Trial.
75,885 results
You have reached the last available page of results. Please see the User Guide for more information.